Abstract
In this work, nine 6-fluoro-triazolo-benzothiazole derivatives were prepared and evaluated for in vitro antimitotic activity. In addition, in silico study was also done using tubulin protein (PDB: 6QQN) by molecular docking method. Results revealed that TZ2 and TZ9 were the most active compounds with antimitotic action opposing the standard drug, aspirin. Results of molecular docking exhibited the inhibitory potential of triazolo-benzothiazole against tubulin protein. The mitotic study indicates the efficacy of triazolo- benzothiazole analogues in inhibiting the proliferation of cancer cells either by promoting microtubule formation or affecting microtubules, thereby preventing microtubule breakdown.
| Original language | English |
|---|---|
| Pages (from-to) | 887-894 |
| Number of pages | 8 |
| Journal | Pharmacia |
| Volume | 70 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2023 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- 1,2,4-triazole
- Benzothiazole
- antimitotic activity
- aspirin
- cancer
- mung beans
Fingerprint
Dive into the research topics of 'In vitro antimitotic activity and in silico study of some 6-fluoro-triazolo-benzothiazole analogues'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver